Tower Research Capital (TRC)’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $21.9K | Sell |
|
|||||
|
2025
Q2 | $82.3K | Buy |
|
|||||
|
2025
Q1 | $28.6K | Sell |
|
|||||
|
2024
Q4 | $42.5K | Buy |
|
|||||
|
2024
Q3 | $38.7K | Sell |
|
|||||
|
2024
Q2 | $338K | Buy |
|
|||||
|
2024
Q1 | $51.9K | Sell |
|
|||||
|
2023
Q4 | $709K | Buy |
|
|||||
|
2023
Q3 | $53.6K | Buy |
|
|||||
|
2023
Q2 | $65.6K | Sell |
|
|||||
|
2023
Q1 | $75K | Buy |
|
|||||
|
2022
Q4 | $18K | Sell |
|
|||||
|
2022
Q3 | $144K | Buy |
|
|||||
|
2022
Q2 | $73K | Sell |
|
|||||
|
2022
Q1 | $370K | Buy |
|
|||||
|
2021
Q4 | $25K | Sell |
|
|||||
|
2021
Q3 | $85K | Buy |
|
|||||
|
2021
Q2 | $46K | Sell |
|
|||||
|
2021
Q1 | $42K | Buy |
|
|||||
|
2020
Q4 | $21K | Sell |
|
|||||
|
2020
Q3 | $266K | Buy |
|
|||||
|
2020
Q2 | $88K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $10K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $40K | Sell |
|
|||||
|
2018
Q1 | $50K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $136K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $37K | Buy |
|
|||||
|
2016
Q4 | $27K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $18K | Buy |
|
|||||
|
2016
Q1 | $10K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $52K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $10K | Sell |
|
|||||
|
2014
Q3 | $55K | Buy |
|